research use only
Cat.No.S3130
|
In vitro |
DMSO
: 49 mg/mL
(200.56 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 244.31 | Formula | C10H16N2O3S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 58-85-5 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2 | ||
| In vitro |
Biotin (Vitamin B7) is necessary for cell growth, the production of fatty acids, and the metabolism of fats and amino acids. It plays a role in the citric acid cycle, which is the process by which biochemical energy is generated during aerobic respiration. This compound is a coenzyme for carboxylase enzymes, involved in the synthesis of fatty acids, isoleucine, and valine, and in gluconeogenesis. In addition, it is widely used throughout the biotechnology industry to conjugate proteins for biochemical assays. |
References |
|
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06390241 | Not yet recruiting | Breast Cancer |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
June 2024 | Phase 1 |
| NCT06313398 | Recruiting | Sickle Cell Disease|Thalassemia|Hemoglobinopathy |
National Heart Lung and Blood Institute (NHLBI)|Children''s National Research Institute|National Institutes of Health Clinical Center (CC) |
May 15 2024 | Early Phase 1 |
| NCT06242288 | Recruiting | Acne Vulgaris |
Mostafa Bahaa|Tanta University |
January 30 2024 | Phase 3 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.